Schrödinger, (SDGR) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
225
Total Shares Held
61.85M
Total Value
$1.19B
Institutional Holding %
84.95%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
BlackRock | 8.80M | 12.08% | $169.70M |
BILL & MELINDA GATES FOUNDATION TRUST | 6.98M | 9.59% | $134.68M |
VANGUARD | 6.61M | 9.08% | $127.55M |
RUBRIC | 5.00M | 6.87% | $96.45M |
SUMITOMO MITSUI TRUST | 3.51M | 4.82% | $67.72M |
NIKKO ASSET AMERICAS | 2.46M | 3.39% | $47.50M |
STATE STREET | 2.32M | 3.18% | $44.69M |
MASSACHUSETTS FINANCIALRVICES CO | 2.28M | 3.13% | $43.97M |
ARK | 2.21M | 3.03% | $42.61M |
LAZARD ASSET | 1.70M | 2.34% | $32.81M |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Akinsanya Karen | President Of R&D, Therapeutics | M-Exempt | 3.35K | $9.77K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | M-Exempt | 13.38K | $43.08K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | S-Sale | 8.38K | $210.39K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | S-Sale | 5.00K | $125.55K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | S-Sale | 3.35K | $83.62K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | M-Exempt | 13.38K | $43.08K | Apr 14, 2025 |
Akinsanya Karen | President Of R&D, Therapeutics | M-Exempt | 3.35K | $9.77K | Apr 14, 2025 |
Van Kralingen Bridget A | Director | A-Award | 17.05K | $358.39K | Mar 07, 2025 |
Van Kralingen Bridget A | Director | A-Award | 10.00K | $- | Mar 07, 2025 |
Van Kralingen Bridget A | Director: | - | $- | Mar 07, 2025 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
SUMITOMO MITSUI TRUST | +1.32M | +60.22% | Jan 28, 2025 |
RUBRIC | +1.31M | +35.67% | Feb 14, 2025 |
NIKKO ASSET AMERICAS | +1.28M | +108.72% | Feb 10, 2025 |
BAILLIE GIFFORD | -926.59K | -46.77% | Jan 31, 2025 |
UBS ASSET AMERICAS | -537.89K | -24.93% | Feb 14, 2025 |
AMERIPRISE FINANCIAL | -402.21K | -74.43% | Feb 14, 2025 |
CITADEL | -400.66K | -78.77% | Feb 14, 2025 |
UBS | +350.73K | +748.43% | Feb 14, 2025 |
MASSACHUSETTS FINANCIALRVICES CO | +334.13K | +17.18% | Feb 12, 2025 |
FMR | -311.36K | -37.28% | Feb 13, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 15, 2025
144
Form 144 - Report of proposed sale of securities
Apr 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
144
Form 144 - Report of proposed sale of securities
Mar 06, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
144
Form 144 - Report of proposed sale of securities
Mar 03, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 19, 2025
144
Form 144 - Report of proposed sale of securities
Feb 18, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 12, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 12, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 12, 2025
Related Metrics
Explore detailed financial metrics and analysis for SDGR.